n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine has been researched along with nitroarginine in 2 studies
Studies (n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine) | Trials (n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine) | Recent Studies (post-2010) (n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine) | Studies (nitroarginine) | Trials (nitroarginine) | Recent Studies (post-2010) (nitroarginine) |
---|---|---|---|---|---|
214 | 5 | 58 | 3,935 | 11 | 175 |
Protein | Taxonomy | n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine (IC50) | nitroarginine (IC50) |
---|---|---|---|
Nitric oxide synthase, endothelial | Bos taurus (cattle) | 1.2 | |
Nitric oxide synthase, endothelial | Homo sapiens (human) | 0.38 | |
Nitric oxide synthase, brain | Homo sapiens (human) | 1.265 | |
Nitric oxide synthase, brain | Rattus norvegicus (Norway rat) | 4.12 | |
Nitric oxide synthase, inducible | Mus musculus (house mouse) | 0.5 | |
Nitric oxide synthase, inducible | Homo sapiens (human) | 6.2 | |
Nitric oxide synthase, brain | Mus musculus (house mouse) | 0.5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Auchampach, JA; Bhattacharya, S; Black, RG; Bolli, R; Kodani, E; Takano, H; Tang, XL; Yang, Z | 1 |
Galun, E; Matot, I; Rivo, J; Zeira, E | 1 |
2 other study(ies) available for n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine and nitroarginine
Article | Year |
---|---|
A(1) or A(3) adenosine receptors induce late preconditioning against infarction in conscious rabbits by different mechanisms.
Topics: Adenine; Adenosine; Animals; Binding, Competitive; Cell Line; Consciousness; Decanoic Acids; Humans; Hydroxy Acids; Iodine Radioisotopes; Ischemic Preconditioning, Myocardial; Membranes; Myocardial Infarction; Nitroarginine; Norbornanes; Phenethylamines; Rabbits; Radioligand Assay; Receptor, Adenosine A3; Receptors, Purinergic P1 | 2001 |
Activation of A3 adenosine receptors attenuates lung injury after in vivo reperfusion.
Topics: Adamantane; Adenosine; Adenosine A3 Receptor Agonists; Adenosine A3 Receptor Antagonists; Animals; ATP-Binding Cassette Transporters; Cats; Dihydropyridines; Enzyme Inhibitors; Hemodynamics; Histamine; In Vitro Techniques; KATP Channels; Lung; Morpholines; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitroarginine; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Inwardly Rectifying; Pulmonary Artery; Reperfusion Injury | 2004 |